BLBei Lv

Bei Lv

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bei Lv has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Hui Zheng

    The Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    2 shared publications
  • Bo‐Zhu Chen

    The Acupuncture and Tuina School Chengdu University of Traditional Chinese Medicine Chengdu China

    1 shared publication
  • Can Hua

    Department of Traditional Chinese Medicine, Dazhou Dachuan District People's Hospital (Dazhou Third People's Hospital), Dazhou, China

    1 shared publication
  • Chao-Rong Xie

    Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, No.1166 Liutai Avenue, Wenjiang District, Chengdu, 611100, China, +86 28-61800000

    1 shared publication
  • Jianjiao Mou

    Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, No.1166 Liutai Avenue, Wenjiang District, Chengdu, 611100, China, +86 28-61800000

    1 shared publication
  • Li Lin

    The Acupuncture and Tuina School Chengdu University of Traditional Chinese Medicine Chengdu China

    1 shared publication

Latest Publications

  • Evaluating comparative effect of non‐pharmacological interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta‐analysis

    by Bei Lv, Yu‐Xin Zhang, Qing‐Feng Tao, Li Lin, Xin‐Yu Li, Bo‐Zhu Chen, Hui Zheng

    Background and aims: Non‐pharmacological therapies are critical for disease management, particularly when pharmacological approaches are limited. Investigating their role as adjuncts to pharmacotherapy to improve outcomes in opioid use disorder (OUD) is of substantial clinical importance. This study aimed to evaluate the efficacy of non‐pharmacological therapies as adjuncts to opioid agonist therapy (OAT) management for OUD. Methods: We systematically searched PubMed, Cochrane Controlled Register of Trials, Embase and Web of Science from inception to 8 February 2025 for randomized controlled trials (RCTs) comparing OAT alone versus OAT combined with non‐pharmacological interventions in OUD. Outcomes of interest included treatment retention [assessed via odds ratios (ORs)], negative urine test results (specimen and the longest duration of continuous drug abstinence) and opioid craving scores [both evaluated via standard mean differences (SMDs)]. Bayesian network meta‐analysis (NMA) using a random‐effects consistency model was conducted to compare the relative effects of all non‐pharmacological interventions. Local inconsistency was evaluated through node‐splitting analysis, and global inconsistency was assessed using the non‐consistency model. The certainty of the evidence was assessed using the GRADE framework (Grading of Recommendations, Assessment, Development and Evaluation) for network meta‐analysis. Results: Forty‐two RCTs involving 5113 participants were included. For treatment retention, contingency management (CM) combined with OAT likely results in an increase [low‐certainty evidence; OR = 1.64, 95% credible interval (CrI) = 1.03–2.57], while the combination of OAT with contingency management plus cognitive behavioral therapy (CBT + CM; very low‐certainty evidence; OR = 2.47, 95% CrI = 1.10–5.67) or with enhanced methadone services (EMS; very low‐certainty evidence; OR = 5.48, 95% CrI = 1.47–22.61) may result in an increase, compared with OAT alone. No intervention statistically significantly improved opioid‐negative urine tests over OAT alone (very low certainty). For craving, acupuncture (very low certainty; SMD = −2.13, 95% CrI = − 3.09 to −1.15) and sham acupuncture (low certainty; SMD = −1.49, 95% CrI = − 2.69 to −0.31) combined with OAT may reduce craving scores. Conclusion: Contingency management, as adjunctive therapies for opioid agonist therapy (OAT), may improve treatment retention in patients with opioid use disorder compared with traditional OAT. Enhanced methadone services and contingency management plus cognitive behavioral therapy may improve treatment retention too but the evidence is very uncertain. Compared with OAT, sham acupuncture as an adjunct therapy may help reduce opioid cravings; acupuncture may reduce cravings too but evidence is very uncertain.

  • Open Access

    Face-to-Face Versus Digital, Telephone-Delivered, and Self-Help Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Systematic Review and Bayesian Indirect Treatment Comparison Meta-Analysis

    by Qing-Feng Tao, Can Hua, Xiao Zhuo, Jian-Jiao Mou, Chao-Rong Xie, Yu-Xin Zhang, Bei Lv, Xin-Ying Niu, Min Chen, Hui Zheng

    Background: Cognitive behavioral therapy (CBT) is recommended for irritable bowel syndrome (IBS). However, it remains unclear whether face-to-face CBT is as effective as digital, self-help, or telephone-delivered CBT for IBS. Objective: This study aimed to estimate the relative effects of face-to-face CBT compared with digital, telephone-delivered, and self-help CBT for IBS and to assess whether there are adequate effective sample sizes to support the findings. Methods: Ovid MEDLINE, Embase, and the Cochrane Library were searched up to September 27, 2025. Randomized controlled trials of face-to-face, digital, self-help, or telephone-delivered CBT for IBS in adults were included. The primary outcome was the IBS symptom severity scale. The secondary outcomes were IBS quality of life and abdominal pain intensity. A Bayesian random effects model was used for the meta-analysis. The effective and required sample sizes were calculated to estimate whether the sample sizes were adequate. The certainty of evidence was evaluated using the Confidence in Network Meta-Analysis Framework. The risk of bias of included studies was assessed using the Cochrane Collaboration’s risk of bias tool (version 2). Results: We analyzed 22 studies involving 3161 participants. The number of participants ranged between 28 and 558. The mean (SD) age of participants was 37.2 (10.6) years, and 78.6% (2485/3161) were women. These randomized controlled trials were published between 2003 and 2025. We found that face-to-face CBT had similar effects compared with digital CBT (mean difference [MD] −0.89, 95% credible interval [CrI] −20.78 to 18.73), self-help CBT (MD −1.73, 95% CrI −21.03 to 17.80), and telephone-delivered CBT (MD −0.76, 95% CrI −20.86 to 19.38) in improving IBS symptom severity scale scores. The comparison between face-to-face CBT and self-help CBT had sufficient effective sample sizes (375/140), whereas the effective sample sizes for comparisons with digital CBT (347/729) and telephone-delivered CBT (140/627) were insufficient. The certainty of evidence was moderate to low. Similarly, in improving quality of life and abdominal pain intensity, face-to-face CBT showed equal effect compared with digital and self-help CBT, with insufficient sample sizes and low to very low evidence certainty. Conclusions: This is the first Bayesian meta-analysis to incorporate effective and required sample size calculations for comparisons among CBT modalities in IBS. We analyzed continuous data of the outcomes. Meanwhile, we computed the effective and required sample sizes, thereby quantifying the informational adequacy of each comparison. Our Bayesian meta-analysis demonstrated significant potential for digital, self-help, and telephone-delivered CBT for patients with IBS, but the effective sample sizes of most comparisons were inadequate. Digital, self-help, and telephone-delivered CBT can serve as important options for managing IBS in clinical practice. Given high heterogeneity, high risk of bias, and inadequate effective sample sizes, more high-quality studies are warranted.